Jiuweihuaban pill for plaque psoriasis
Part of Skin clinical trials.
This trial tests a Chinese herbal pill for people with mild-to-moderate plaque psoriasis. The pill is meant to reduce redness, scaling, and inflammation by targeting a specific pattern in traditional Chinese medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with plaque psoriasis (the common scaly red patches).
- Your psoriasis covers at least 3% but no more than 10% of your body surface, and your symptoms are moderate or worse.
- You have not used strong psoriasis pills or injections (like methotrexate, cyclosporine, or biologics) in the past month or longer, depending on the drug.
- You have not used prescription creams or light therapy for psoriasis in the past 2–4 weeks.
- You are willing to stop other psoriasis treatments and take only the study pill.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
This trial tests an experimental pill called D-2570 for people with moderate to severe plaque psoriasis. It aims to see if the pill can safely improve skin symptoms like redness, scaling, and thickness.
This study tests a new oral pill (HSK47388) for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective in reducing the severity and area of psoriasis over 12 weeks.
This study tests a new herbal ointment containing chitosan nanocrystals for people with stable, mild-to-moderate plaque psoriasis. The ointment is applied to the skin over 8 weeks to see if it reduces redness, scaling, and itching.
This early-phase study tests an experimental oral tablet (UA026) in people with moderate to severe plaque psoriasis. The purpose is to see how safe and effective the drug is, and how it works in the body.
This trial tests an oral medication called ICP-332 versus a placebo (a pill with no active drug) for people with moderate to severe plaque psoriasis. The goal is to see if ICP-332 can improve skin symptoms and be safe.
Hear when a new Plaque Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.